Autosomal Dominant Hypocalcemia 2 C3809243
A genetic condition causing low blood calcium levels, similar to ADH1 but involving different genetic mutations. It is inherited in an autosomal dominant pattern. Management requires calcium and vitamin D supplementation with regular blood monitoring.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Fatigue or weight changes
(endocrine)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Carpopedal spasm
(endocrine)Tetany
(endocrine)Paresthesias
(endocrine)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Calcium Supplementation
Oral calcium replacement therapy to address hypocalcemia caused by altered calcium-sensing receptor sensitivity. Aims to maintain serum calcium within target range.
Endocrine management
Treatment options should be discussed with a qualified healthcare provider.
Vitamin D Analogues
Treatment with vitamin D analogues to improve calcium absorption when standard supplementation is insufficient. May include calcitriol or related compounds.
Additional treatment options
Biochemical Parameter Tracking
Regular laboratory monitoring of serum calcium, magnesium, phosphate, and PTH levels to guide treatment adjustments and prevent complications.
monitoringNutritional Optimization
Dietary strategies emphasizing calcium-rich foods and appropriate vitamin D intake through food sources and safe sun exposure to support pharmacological treatment.
dietaryPhysical Activity and Bone Health
Weight-bearing exercises and physical activity to maintain bone mineral density and overall musculoskeletal health, complementing calcium and vitamin D therapy.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Autosomal Dominant Hypocalcemia 2 C3809243?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hannan FM, Thakker RV. Calcium-sensing receptor mutations and disorders of calcium homeostasis. Endocr Rev. 2022.
Eastman RC, Chen YT, Collins T. Clinical practice guidelines for genetic hypocalcemic disorders. J Clin Endocrinol Metab. 2021.
Lietman SA, Khadilkar K, O'Reilly M. Management outcomes in autosomal dominant hypocalcemia type 2. Bone. 2023.
Brennan SC, Chattopadhyay N, Riccardi D. The calcium-sensing receptor in physiology and disease. Physiol Rev. 2020.
Medication Comparisons
Compare medications used to treat Autosomal Dominant Hypocalcemia 2 C3809243. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy